Farther Finance Advisors’s Olema Pharmaceuticals OLMA Stock Holding History

Farther Finance Advisors’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$259	Sell	30 -150	-83%	-$1.63K	﹤0.01%	5845
2026 Q2	$2.25K	Hold	180	–	–	﹤0.01%	5132
2026 Q1	$2.72K	Hold	180	–	–	﹤0.01%	4769
2025 Q4	$4.5K	Buy	180 +150	+500%	+$2.67K	﹤0.01%	4369
2025 Q3	$294	Sell	30 -6,809	-100%	-$40.9K	﹤0.01%	4644
2025 Q2	$29.1K	Buy	6,839 +5,866	+603%	+$26.2K	﹤0.01%	2442
2025 Q1	$3.25K	Buy	+973	New	+$4.89K	﹤0.01%	3214

Other funds holding OLMA

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's OLMA Position: Q3 2026 in Review

Farther Finance Advisors reduced its Olema Pharmaceuticals (OLMA) stake by 83% in Q3 2026, selling an estimated $1.63K and leaving 30 shares worth $259. The position accounts for ﹤0.01% of the portfolio, ranked #5845.

Farther Finance Advisors first reported a position in OLMA in Q1 2025 and has held it in 7 quarters since. The position peaked at $29.1K in Q2 2025. 3 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

Farther Finance Advisors held 30 shares of Olema Pharmaceuticals worth $259 as of Q3 2026.
Farther Finance Advisors sold 150 Olema Pharmaceuticals shares in Q3 2026, an estimated $1.63K.
Olema Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5845 holding.
Farther Finance Advisors first reported a position in Olema Pharmaceuticals in Q1 2025 and has held it in 7 quarters since.
Farther Finance Advisors's Olema Pharmaceuticals position peaked at $29.1K in Q2 2025.
3 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.